Gender differences in the control of multiple cardiovascular disease risk factors in type 2 diabetes patients

37. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998; 339: 1093–1099. 38. Meng Q, Lima JA, Lai H, et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J AIDS 2002; 30; 306–310. 39. Pewsner D, Jüni P, Egger M, et al. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. Br Med J 2007; 335: 711. 40. Devereux RB. Is the electrocardiogram still useful for detection of left ventricular hypertrophy? Circulation 1990; 81: 1144–1146. 41. Michael AB. Left ventricular hypertrophy: An overlooked cardiovascular risk factor. Cleveland Clin J Med 2010; 77(6): 381–387. 42. Ogunmodede A. Electrocardiographic and echocardiographic abnormalities in HIV patients seen at University of Ilorin Teaching Hospital, Ilorin. Part II dissertation. West Africa College of Physicians, October 2011. 43. Villa A, Foresti V, Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res 1995; 5: 48–52. 44. Kocheril AG, Bokhari SAJ, Bastsford WP, Sinusas AJ. Role of antiretroviral treatment in prolongating QTc interval in HIV positive patients. J Infect 2007; 54(6): 597–602. 45. Alessandra F, Nicola P, Angelo DS, et al. QTc interval prolongation in HIV-infected patients: a case–control study by 24-hour Holter ECG recording. BMC Cardiovasc Disord 2012; 12: 124. 46. Anson BD, Weaver JG, Ackerman MJ, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet 2005; 365: 682–686. 47. Eisenhauer MD, Eliasson AH, Taylor AJ, et al. Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest 1994; 105: 389–395. 48. Von Seidlein L, Jaffar S, Greenwood B. Prolongation of QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg 1997; 56: 494–497.